Topoisomerase inhibitor

Revision as of 13:03, 30 June 2009 by Mdoherty (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Topoisomerase inhibitor

Articles

Most recent articles on Topoisomerase inhibitor

Most cited articles on Topoisomerase inhibitor

Review articles on Topoisomerase inhibitor

Articles on Topoisomerase inhibitor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Topoisomerase inhibitor

Images of Topoisomerase inhibitor

Photos of Topoisomerase inhibitor

Podcasts & MP3s on Topoisomerase inhibitor

Videos on Topoisomerase inhibitor

Evidence Based Medicine

Cochrane Collaboration on Topoisomerase inhibitor

Bandolier on Topoisomerase inhibitor

TRIP on Topoisomerase inhibitor

Clinical Trials

Ongoing Trials on Topoisomerase inhibitor at Clinical Trials.gov

Trial results on Topoisomerase inhibitor

Clinical Trials on Topoisomerase inhibitor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Topoisomerase inhibitor

NICE Guidance on Topoisomerase inhibitor

NHS PRODIGY Guidance

FDA on Topoisomerase inhibitor

CDC on Topoisomerase inhibitor

Books

Books on Topoisomerase inhibitor

News

Topoisomerase inhibitor in the news

Be alerted to news on Topoisomerase inhibitor

News trends on Topoisomerase inhibitor

Commentary

Blogs on Topoisomerase inhibitor

Definitions

Definitions of Topoisomerase inhibitor

Patient Resources / Community

Patient resources on Topoisomerase inhibitor

Discussion groups on Topoisomerase inhibitor

Patient Handouts on Topoisomerase inhibitor

Directions to Hospitals Treating Topoisomerase inhibitor

Risk calculators and risk factors for Topoisomerase inhibitor

Healthcare Provider Resources

Symptoms of Topoisomerase inhibitor

Causes & Risk Factors for Topoisomerase inhibitor

Diagnostic studies for Topoisomerase inhibitor

Treatment of Topoisomerase inhibitor

Continuing Medical Education (CME)

CME Programs on Topoisomerase inhibitor

International

Topoisomerase inhibitor en Espanol

Topoisomerase inhibitor en Francais

Business

Topoisomerase inhibitor in the Marketplace

Patents on Topoisomerase inhibitor

Experimental / Informatics

List of terms related to Topoisomerase inhibitor

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Topoisomerase inhibitors are chemotherapy agents designed to interfere with the action of topoisomerase enzymes (topoisomerase I and II), which are enzymes that control the changes in DNA structure by catalyzing the breaking and rejoining of the phosphodiester backbone of DNA strands during the normal cell cycle.

In recent years, topoisomerase inhibitors have become popular targets for cancer chemotherapy treatments. It is thought that topoisomerase inhibitors block the ligation step of the cell cycle, and that topoisomerase I and II inhibitors interfere with the transcription and replication of DNA by upsetting proper DNA supercoiling.

A commonly prescribed class of topoisomerase inhibitors are fluoroquinolones.


Template:QuinoloneAntiBiotics

Template:SIB Template:WH Template:WikiDoc Sources